Richmond University Medical Center is taking precautions to guard against Coronavirus. VISITOR POLICY • COVID-19 VACCINATIONS

CURRENT EMERGENCY DEPARTMENT WAIT TIME:

844.934.2273

Chinese (Simplified)

Chinese (Traditional)

Kurdish (Kurmanji)

Myanmar (Burmese)

Scottish Gaelic

Home » About » Richmond Quality ACO

Richmond Quality ACO in Staten Island NY | RUMCSI

ACO Name and Location

Richmond Quality, LLC
355 Bard Avenue
Staten Island, NY 10310

ACO Primary Contact

Primary Contact Name	Jasmin Eversley-Danso
Primary Contact Phone Number	718 818-1990
Primary Contact Email Address	Jeversley-danso@rumcsi.org

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture (Enter Y or N)
Nicolette Filitis	N
Amboy Medical Practice PC	N
Neil Nepola MD	N
Subbaraju Polepalli	N
Richmond Medical Center	N
The Narrows Medical Group PC	N
Premier Medical Pllc	N
Leroy Hardyal, MD	N
GEORGE JOHN AYYAD PHYSICIAN PC	N
Peter Stathopoulos	N
Deepak Vadhan MD FCCP PC	N
Deborah A. Aanonsen Do Pllc	N
Frank Scafuri Iii D.O. P.C.	N

ACO governing body:

Member	Member’s Voting Power –Expressed as a percentage or number	Membership Type	ACO Participant Legal Business Name/DBA, if Applicable
Last Name	First Name	Title/Position
LaBarbera, MD	Marianne	Chairman of the Board	1	ACO Participant Representative	Amboy Medical Practice, PC
Ayyad, MD	George	Vice President	1	ACO Participant Representative	George John Ayyad,
Naing, MD	Sundee	Vice President	1	ACO Participant Representative	Amboy Medical Practice, PC
Scafuri, MD	Frank	Secretary	1	ACO Participant Representative	Frank Scafuri III DO PC
Murray	Dave	Co-Chair Finance Committee	1	ACO Participant Representative	Richmond Medical Center
Eversley-Danso	Jasmin	Co-Chair, Performance Improvement	0	ACO Participant Representative	Richmond Medical Center
Stathopoulos, MD	Peter	Co-Chair, Performance Improvement	1	ACO Participant Representative	Amboy Medical Practice, PC
Salhany, MBA, FACHE	Richard	Executive Director	1	ACO Participant Representative	Richmond Medical Center
Messina, PhD, FACHE	Daniel	Associate Executive Director	1	ACO Participant Representative	Richmond Medical Center
Carpenito, MD	Pietro	Medical Director	1	ACO Participant Representative	Richmond Medical Center
Fultz	Mary	Member	1	Member Beneficiary	N/A

Key ACO clinical and administrative leadership:

Position	Name
ACO Executive	Richard Salhany, MBA, FACHE
Medical Director	Pietro Carpenito, MD
Compliance Officer	Dale Weber, R.N.
Quality Assurance/Improvement Officer	Jasmin Eversley-Danso , MS, LSSMBB

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Finance Committee	Dave Murray and Marianne LaBarbera, MD, Co-Chairpersons
Performance Improvement Committee	Peter Stathopoulos, MD and Jasmin Eversley-Danso, Co-Chairpersons

Types of ACO participants, or combinations of participants, that formed the ACO:

Hospital employing ACO professionals
Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Second Agreement Period
- Performance Year 2020, $3,365,658
- Performance Year 2019, $3,462,333
- Performance Year 2018, $0

First Agreement Period
- Performance Year 2017, $4,871,913
- Performance Year 2016, $3,473,744
- Performance Year 2015, $1,830,512

Shared Savings Distribution

Second Agreement Period

Performance Year 2020
- Proportion invested in infrastructure: 25 %
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Performance Year 2019
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Performance Year 2018
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

First Agreement Period

Performance Year 2017
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Performance Year 2016
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants:50%

Performance Year 2015
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Quality Performance Results

2020 Quality Performance Results:

ACO #	Measure Name	Rate	ACO Mean
ACO-8	Risk Standardized, All Condition Readmission	15.09	15.07
ACO-38 [1,2]	Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions	48.10	49.50
ACO-43 [3]	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	0.61	0.95
ACO-13	Falls: Screening for Future Fall Risk	96.20	84.97
ACO-14	Preventive Care and Screening: Influenza Immunization	79.41	76.03
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	82.86	81.67
ACO-18	Preventive Care and Screening: Screening for Depression and Follow-up Plans	90.73	71.46
ACO-19	Colorectal Cancer Screening	65.96	72.59
ACO-20	Breast Cancer Screening	71.80	74.05
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	81.75	83.37
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	15.20	14.70
ACO-38	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions	58.73	59.00
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	73.24	72.87

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613